ABIVAX SA (ABVX) Surged by 58% in Q4

2 months ago 46

Soumya Eswaran

Thu, April 2, 2026 astatine 8:45 AM CDT 3 min read

TimesSquare Capital Management, an equity concern absorption company, released its “U.S. Small Cap Growth Strategy” fourth-quarter 2025 capitalist letter. A transcript of the missive tin beryllium downloaded here. The strategy returned 3.70% (gross) and 3.45% (net) successful the 4th fourth compared to a 1.22% instrumentality for the Russell 2000 Growth Index. In 2025, the strategy returned 6.91% (gross) and 5.85% (net) compared to 13.01% for the index. Global equity markets ended the 4th connected a affirmative note, with Europe leading, followed by Emerging Markets. In astir markets, ample caps outperformed tiny caps. The commercialized truce betwixt the United States and China was prolonged for an further year, but planetary geopolitical concerns, whether related to tariffs oregon not, persisted. Third-quarter GDP exceeded expectations, but user caution persists amid ongoing labor-market softening, influencing the Fed’s determination connected interest-rate cuts. Please reappraisal the Strategy’s apical 5 holdings to summation insights into their cardinal selections for 2025.

In its fourth-quarter 2025 capitalist letter, TimesSquare Capital U.S. Small Cap Growth Strategy highlighted stocks similar ABIVAX Société Anonyme (NASDAQ:ABVX). ABIVAX Société Anonyme (NASDAQ:ABVX) is simply a French clinical-stage biotechnology institution that focuses connected processing treatments for bowel diseases. On April 1, 2026, ABIVAX Société Anonyme (NASDAQ:ABVX) closed astatine $114.97 per share. One-month instrumentality of ABIVAX Société Anonyme (NASDAQ:ABVX) was -2.01%, and its shares gained 1,885.66% implicit the past 52 weeks. ABIVAX Société Anonyme (NASDAQ:ABVX) has a marketplace capitalization of $9.11 billion.

TimesSquare Capital U.S. Small Cap Growth Strategy stated the pursuing regarding ABIVAX Société Anonyme (NASDAQ:ABVX) successful its 4th fourth 2025 capitalist letter:

"Our preferences among Health Care stocks are those companies providing caller therapies for unmet needs that bid premium pricing, oregon specialized work providers. That includes the biopharma developer of treatments for bowel diseases, ABIVAX Société Anonyme (NASDAQ:ABVX). We archetypal purchased Abivax successful the summer, aft it reported beardown objective proceedings results for its obefazimod attraction to code ulcerative colitis successful a longer-lasting mode with less broadside effects than existent medicines. Toward the extremity of the year, determination was speculation that Abivax was successful the acquisition crosshairs of a larger pharmaceutical company, and we trimmed our presumption arsenic it roseate by 58%."

30 Biggest Biotechnology Companies successful the World

ABIVAX Société Anonyme (NASDAQ:ABVX) is not connected our database of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 72 hedge money portfolios held ABIVAX Société Anonyme (NASDAQ:ABVX) astatine the extremity of the 4th quarter, up from 56 successful the erstwhile quarter. While we admit the imaginable of ABIVAX Société Anonyme (NASDAQ:ABVX) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article